Toll-free: (877) 631-6311 | Local: (602) 626-3100 |
Office Closed
.(JavaScript must be enabled to view this email address)
Premium Research Service

Healthy Returns

Helping you invest in tomorrow’s healthcare innovations and biotech breakthroughs that are already delivering life-changing returns

Chief Editor: Chris Wood

Sign Up for a Trial Subscription to Healthy Returns

You can cancel at any time!

No minimum terms. No hidden fees. No surprise price increases.

Start My Subscription Today

Investment Risk/Reward

Low Risk

Approx Positions: 15

Number of positions, portfolio risk, and returns may vary. These are estimates based upon our track record and historical data.

Chris Wood

Meet Chris Wood

Chief Investment Officer, Healthcare & Biotech at Mauldin Economics

A 20-year market veteran with 13 years of professional experience, Chris is known for his ability to consistently pinpoint—and deliver—stocks with double- and triple-digit profit potential. In fact, he’s already hard at work… researching the next round of stocks that are set to profit big from three massive megatrends in healthcare that should deliver an Rx of profits for Healthy Returns subscribers. Read more about Chris Wood.

What’s Waiting for You:

  • Invest in your portfolio health with one wealth-boosting stock every month

  • Timely, detailed buy and sell alerts

  • An up-to-date model portfolio so you know exactly how your positions are performing

  • “Special Release" market insight letters and reports

  • Access to our gold star customer service team

Access investments designed to deliver a shot at double- and triple-digit gains at the affordable rate of just $199 each year.

There is a perfect storm happening in healthcare, and ignoring it could affect your personal wealth.

MarketWatch says, “Health is the new wealth thanks to the coronavirus pandemic.”

Barron’s says, “Biotech stocks are poised to rise...”

Kiplinger’s calls it a “Health Care Revolution.”

And the Financial Times writes that certain biotech stocks are “soaring as coronavirus fuels investor boom.”

In fact, MarketWatch goes on to point out that, “Investors are switching their attention from what was previously considered important”—the once-booming real estate and hospitality sectors—"to what is truly important: Human Health.”

Consider this...

...10,000 Baby Boomers, on average, turn 65 each day... and ALL Boomers will have reached this milestone by 2030

...By 2034, older adults will outnumber children for the first time in US History

...$3.8 trillion was spent on healthcare in 2019 with $4 trillion expected spending in 2020. Baby Boomer healthcare needs are expected to push healthcare spending to $6 trillion in just 7 years.

And that's just in the US. The world population is getting older, too. And thanks to life-saving drugs, therapies, and medical technologies, lifespans will keep getting longer—and that means the market for these treatments will grow right along with it.

In 2020 alone, we saw the NASDAQ Biotechnology Index (^NBI) rise a whopping 15.07%* and the NASDAQ Health Care Index (^IXHC) hop up by 16.72%*... both outperforming the trusted and “go-to” S&P 500... which only reached heights of 1.98%.* [*current as of Q3]

In other words: This isn't some short-lived trend. Healthcare has been heating up for a while, and investors who enter now are set to discover some of the most exciting and lucrative investment opportunities of the next two decades.

The treatments and technologies being developed today are set to transform the healthcare marketplace as we know it—and the sooner treatments get to market, the sooner they can help the people who need them most (and the sooner you could profit).

But long before COVID-19 shoved healthcare and biotech into the limelight, promising explosive returns to whomever “got there first,” Chris Wood saw the writing on the wall.

Chris has been helping his clients locate opportunities for double- and triple-digit gains for over 13 years, specifically in the Healthcare and Biotech sectors.

And now he wants to help you do the same.

It’s all part of his comprehensive research service...

Healthy Returns.

Each month, Chris releases one brand-new investment idea in this wildly profitable sector, helping guide you to lower-risk plays with high profit potential.

His expert analysis and insight will not only ensure that you’re extremely knowledgeable about this market, but that you have every chance to maximize your potential profits and build personal wealth—consistently and reliably.

Best of all, Chris helps you navigate this exciting sector without using riskier trading tools like options or day trading—and without recommending any dangerously volatile penny stocks.

In other words, you can invest in potentially explosive stocks... without having to keep a close eye on them. In fact, Chris does that for you... and so much more.

Here's to YOUR Healthy Returns!

Join the thousands of satisfied Healthy Returns subscribers below.

Here’s what is waiting for you when you fill out the form below:

Healthy Returns
  • One New Investing Opportunity Each Month. Thousands rely on Chris’s unique investing insights to generate their own Healthy Returns. Each month, you’ll receive a deeply researched investing opportunity (high double-digit and triple-digit returns are the norm). You’ll not only understand why Chris chose a company, but you’ll know what type of returns to expect, and how long you should expect to hold. There are twists and turns in any market, but you’ll be armed with a solid plan.

  • Real-Time Buy & Sell Alerts. When you need to make a move, you will know. Timely Buy & Sell Alerts will be sent straight to your email inbox—and will be reiterated in your member area. You will not only know “when to sell” or “when to take a free ride” but you will know exactly why.

  • “Special Release” Market Insights. At least once a month, and sometimes several, Chris shares his “big ideas” on biotech and healthcare. See around the corner before anyone else with these regularly released market musings.

  • A “Done for You” Portfolio. You will be provided with detailed stop-loss, free-ride, and target-buy information. Better information gives you the power to plan and invest appropriately without wasting hours on research.

  • Special Reports & Back Issues. You will have access to every back issue and special report ever issued by Healthy Returns. By assessing past issues and reports, it’s easy to see the high level of service offered through both market ups and downs. Chris isn’t in this business to make himself look good, but instead, to provide you with money-making opportunities.

Join today for just $199 a year!

Gain exclusive access to Chris’s research for just $199 a year. With each new pick regularly seeing returns of 5-10% in the first month (and sometimes more), you’ll quickly be making your money back.

Try out Healthy Returns risk-free!

Though we are sure you’ll be pleased with the fantastic opportunities to profit offered to you each month, you should know: You can cancel at any time!

Plus, for as long as you remain a subscriber, you can relax knowing there will be: No minimum terms. No hidden fees. No surprise price increases.

If for any reason you are unsatisfied, you can cancel your subscription at any time! No questions asked and no hassle. You can count on that.

To get started right away, fill out the order form below.

Account Access Already have an account? Log in

Please enter email to be used when accessing your subscription

* Indicates Required fields

Billing Information

credit cards

* Indicates Required fields

Contact Info

* Indicates Required fields

Please note all investing carries the risk of loss and you should only speculate with capital you are prepared to lose. The fact that we have made information available to you is neither a recommendation that you enter into a particular transaction nor a representation that any investment described herein is suitable or appropriate for you. Many of the investments described by Mauldin Economics involve significant risks, and you should not enter into any transactions unless you fully understand all such risks and have independently determined that such transactions are appropriate for you. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or complete discussion of the risks which are mentioned. You are advised to discuss with your financial advisers your investment options and whether any investment is suitable for your specific needs prior to making any investments. Subscribing to a Mauldin Economics publication does not make us responsible for your investment results, and you will bear the risks of any investment you decide to make. Sometimes our investment recommendations may be wrong or the timing may be off. Furthermore, the investment returns described and detailed above should not be read as a promise or guarantee of your personal returns using Mauldin Economics.

By submitting this order or request, you agree to our Terms & Conditions of Use.

Questions? Need Help? Want to Order Over the Phone?
Call us now at: (602) 626-3100 or (877) 631-6311 (for international callers)

Get in Touch

1417 Sadler Road
PMB 415
Fernandina Beach, FL 32034

Toll-free: (877) 631-6311
Local: (602) 626-3100